<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150131020888N9</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-08-04</date_registration>
      <primary_sponsor>Isfahan University of Medical Sciences, Vice Chancellery of Research and Technology</primary_sponsor>
      <public_title>The Effect of low level LASER on pain and function in subjects with anterior knee pain</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effect of low level laser and placebo laser on pain and function in subjects with patellofemoral pain syndrome: A Pilot Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-06-28</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/32325</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The volunteers will be assigned to three groups randomly using the random numbered table codes. an unaware person in the research method will select the codes from the random numbers table, Blinding description: This study is a Triple-blind  randomized clinical trial (participant, examiner and analyzer) with a parallel design.
LASER is performed by a physical therapist in two groups of laser and placebo. This person has no role in evaluating participants, other sections of treatment and recording information. Participants can not recognize, whether LASER devices  is on or off.
The same physical therapist who is blind to study groups will supervise standard physical therapy in all groups. to ensure participant blinding to study groups they all will receive therapeutic ultrasound in OFF state. 
A comprehensive clinical assessment will be performed by a physical therapist who is unaware of the research groups (student ). 
Data analysis will be done by an unknown person in the research method.</study_design>
      <phase>N/A</phase>
      <hc_freetext>patellofemoral pain syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: standard physical therapy plus low-level LASER group:Participants in this group receive active LASER plus standard physical therapy. LASERs will be used at the beginning of the session before any other intervention. Subjects will receive LASER in supine position. The probe will be in direct and full contact with the tissue at 90 ° angle. The LASER group will be treated with low level Gallium-Aluminum-Arsenide (Ga-Al-As) LASER, with a wavelength of 808 nm, output power of 200 mW, continuous mode, Beam spot size of 1 cm2, dose of 4 J/cm2 (each point), and energy of 4J for 20 seconds on each point. LASER will be radiated over five points around the patella. The total energy and total radiation time for each session will be 20 Jules and 100 seconds (one minute and 40 seconds) respectively. Participants will receive standard physical therapy after completing laser therapy. At first OFF ultrasound will be used over the patella. According to Manchester consensus statement, therapeutic exercises is the treatment of choice for patellofemoral pain syndrome. Each training session will begin with 5 minutes’ warm up, continue with stretching and strengthening exercises, and finally, cool down for 5 minutes. ­Stretching exercises for hamstring, plantar flexors, quadriceps and iliotibial band: 3 repetitions of 30s for each muscle. ­Strengthening exercises: semi squat (0-45 degrees), Seated knee extension (90-45 degrees), SLR , hip abduction with weights (side lying), hip abduction against elastic band (standing), hip lateral rotation against elastic band (sitting).Each exercise will be performed in three sets of 10 repetitions. Interval for rest and recovery between sets will be 3 minutes. External resistance during training will be standardized as 70% of the 1-repetition maximum (1RM). The elastic band resistant will be individualized as maximum resistant which each subject can perform in 10 repetitions (10 RM for Thera Band). Intervention 2: Intervention group: standard physical therapy plus placebo LASER group: The participants in this group receive LASER off plus standard physical therapy. In this group, the LASER device will turn off all the time. Participants will receive standard physical therapy after completing the LASER off Program. At first OFF ultrasound will be used over the patella. According to Manchester consensus statement, therapeutic exercises is the treatment of choice for patellofemoral pain syndrome. Each training session will begin with 5 minutes’ warm up, continue with stretching and strengthening exercises, and finally, cool down for 5 minutes. ­Stretching exercises for hamstring, plantar flexors, quadriceps and iliotibial band: 3 repetitions of 30s for each muscle. ­Strengthening exercises: semi squat (0-45 degrees), Seated knee extension (90-45 degrees), SLR , hip abduction with weights (side lying), hip abduction against elastic band (standing), hip lateral rotation against elastic band (sitting).Each exercise will be performed in three sets of 10 repetitions. Interval for rest and recovery between sets will be 3 minutes. External resistance during training will be standardized as 70% of the 1-repetition maximum (1RM). The elastic band resistant will be individualized as maximum resistant which each subject can perform in 10 repetitions (10 RM for Thera Band). Intervention 3: Control group: standard physical therapy alone: Participants in this group will receive only standard physical therapy. At first OFF ultrasound will be used over the patella. According to Manchester consensus statement, therapeutic exercises are the treatment of choice for patellofemoral pain syndrome. Each training session will begin with 5 minutes’ warm up, continue with stretching and strengthening exercises, and finally, cool down for 5 minutes. ­Stretching exercises for hamstring, plantar flexors, quadriceps and iliotibial band: 3 repetitions of 30s for each muscle. ­Strengthening exercises: semi squat (0-45 degrees), Seated knee extension (90-45 degrees), SLR , hip abduction with weights (side lying), hip abduction against elastic band (standing), hip lateral rotation against elastic band (sitting).Each exercise will be performed in three sets of 10 repetitions. Interval for rest and recovery between sets will be 3 minutes. External resistance during training will be standardized as 70% of the 1-repetition maximum (1RM). The elastic band resistant will be individualized as maximum resistant which each subject can perform in 10 repetitions (10 RM for Thera Band).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Zahra Sadat Rezaeian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jarib Ave. Isfahan University of Medical Sciences, Faculty of Rehabilitation Sciences</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81745-164</zip>
        <telephone>00983137925012; 00983137925042</telephone>
        <email>zrezaeian@yahoo.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Zahra Sadat Rezaeian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jarib Ave. Isfahan University of Medical Sciences, Faculty of Rehabilitation Sciences</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81745-164</zip>
        <telephone>00983137925012; 00983137925042</telephone>
        <email>zrezaeian@yahoo.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Presence anterior or retro patellar pain only in one limb
The report of pain  during a day at least in 2 functional activities including prolonged sitting, climbing stairs, squatting, running, double kneeling, jumping
Score of at least 3 on the visual analog scale (VAS)
The pain will be reported in the squat on one leg for 10 seconds
Subjects have anterior knee pain at least in the past three months
Age from 18 to 40 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Traumatic injuries of the low back and lower extremities
Any signs or symptoms or MRI findings based on intra-articular pathologic conditions such as effusion, meniscal, or cruciate or collateral ligament involvement
Subluxation and dislocation of the patella
Other musculoskeletal injuries in lower extremities
hip or lumbar referred pain
Any symptoms or evidence of knee osteoarthritis in X-rays
Infectious disease, rheumatoid arthritis, autoimmune disease, cancer and systemic diseases
Corticosteroid injections and received physical therapy in the last 3 months, and received opioid and analgesic drugs in the last 72 hours
Epilepsy, heart problems and heart pacemaker
Active athlete
BMI&gt;30kg⁄m^2
Surgery of the lower limbs and lower back
History the use of LASERs due to prejudices about the effect of the intervention</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M22.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chondromalacia patellae</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: standard physical therapy plus low-level LASER group:Participants in this group receive active LASER plus standard physical therapy. LASERs will be used at the beginning of the session before any other intervention. Subjects will receive LASER in supine position. The probe will be in direct and full contact with the tissue at 90 ° angle. The LASER group will be treated with low level Gallium-Aluminum-Arsenide (Ga-Al-As) LASER, with a wavelength of 808 nm, output power of 200 mW, continuous mode, Beam spot size of 1 cm2, dose of 4 J/cm2 (each point), and energy of 4J for 20 seconds on each point. LASER will be radiated over five points around the patella. The total energy and total radiation time for each session will be 20 Jules and 100 seconds (one minute and 40 seconds) respectively. Participants will receive standard physical therapy after completing laser therapy. At first OFF ultrasound will be used over the patella. According to Manchester consensus statement, therapeutic exercises is the treatment of choice for patellofemoral pain syndrome. Each training session will begin with 5 minutes’ warm up, continue with stretching and strengthening exercises, and finally, cool down for 5 minutes. ­Stretching exercises for hamstring, plantar flexors, quadriceps and iliotibial band: 3 repetitions of 30s for each muscle. ­Strengthening exercises: semi squat (0-45 degrees), Seated knee extension (90-45 degrees), SLR , hip abduction with weights (side lying), hip abduction against elastic band (standing), hip lateral rotation against elastic band (sitting).Each exercise will be performed in three sets of 10 repetitions. Interval for rest and recovery between sets will be 3 minutes. External resistance during training will be standardized as 70% of the 1-repetition maximum (1RM). The elastic band resistant will be individualized as maximum resistant which each subject can perform in 10 repetitions (10 RM for Thera Band).</i_keyword>
      <i_keyword>Intervention group: standard physical therapy plus placebo LASER group: The participants in this group receive LASER off plus standard physical therapy. In this group, the LASER device will turn off all the time. Participants will receive standard physical therapy after completing the LASER off Program. At first OFF ultrasound will be used over the patella. According to Manchester consensus statement, therapeutic exercises is the treatment of choice for patellofemoral pain syndrome. Each training session will begin with 5 minutes’ warm up, continue with stretching and strengthening exercises, and finally, cool down for 5 minutes. ­Stretching exercises for hamstring, plantar flexors, quadriceps and iliotibial band: 3 repetitions of 30s for each muscle. ­Strengthening exercises: semi squat (0-45 degrees), Seated knee extension (90-45 degrees), SLR , hip abduction with weights (side lying), hip abduction against elastic band (standing), hip lateral rotation against elastic band (sitting).Each exercise will be performed in three sets of 10 repetitions. Interval for rest and recovery between sets will be 3 minutes. External resistance during training will be standardized as 70% of the 1-repetition maximum (1RM). The elastic band resistant will be individualized as maximum resistant which each subject can perform in 10 repetitions (10 RM for Thera Band).</i_keyword>
      <i_keyword>Control group: standard physical therapy alone: Participants in this group will receive only standard physical therapy. At first OFF ultrasound will be used over the patella. According to Manchester consensus statement, therapeutic exercises are the treatment of choice for patellofemoral pain syndrome. Each training session will begin with 5 minutes’ warm up, continue with stretching and strengthening exercises, and finally, cool down for 5 minutes. ­Stretching exercises for hamstring, plantar flexors, quadriceps and iliotibial band: 3 repetitions of 30s for each muscle. ­Strengthening exercises: semi squat (0-45 degrees), Seated knee extension (90-45 degrees), SLR , hip abduction with weights (side lying), hip abduction against elastic band (standing), hip lateral rotation against elastic band (sitting).Each exercise will be performed in three sets of 10 repetitions. Interval for rest and recovery between sets will be 3 minutes. External resistance during training will be standardized as 70% of the 1-repetition maximum (1RM). The elastic band resistant will be individualized as maximum resistant which each subject can perform in 10 repetitions (10 RM for Thera Band).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: the first session just before the intervention and at the tenth session after the end of the treatment plan. Method of measurement: Visual Analogue Scale (VAS)-Persian version of Kujala questionnaire.</prim_outcome>
      <prim_outcome>Function. Timepoint: the first session just before the intervention and at the tenth session after the end of the treatment plan. Method of measurement: Persian version of Kujala questionnaire- step down test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Isfahan University of Medical Sciences, Vice Chancellery of Research and Technology</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-07-04</approval_date>
        <contact_name>Ethics Committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Secretariat of the Ethics Committee, Room 209, Second Floor, Building No. 4, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
